Clinical Observation on the Treatment of Rheumatoid Arthritisin Early Stage with TongLuoShu Liquid

VernacularTitle:通络舒液治疗早期类风湿关节炎的临床观察
Author: Zhiqiang LV ; Guixiang SUN ; Yongcheng JIN ; Xiangdong ZHOU ; Hui SONG
Publication Type:Journal Article
Keywords: Tongluoshu Liquid; Rheumatoid arthritis; Accumulation of toxic evil
From: International Journal of Traditional Chinese Medicine 2009;31(6):499-500
CountryChina
Language:Chinese
Abstract: Objective To investigate the clinical efficacy of TongluoShu Liquid in treating rheumatoid arthritis at early stage. Methods 100 cases were randomly recruited into a control group and a treatment group with 50 cases in each group. The treatment group was given TongluoShu liquid, 150ml / time, twice a day; and the control group was given Diclofenac Sodium Sustained Release Tablets (Deegan), one granule for each time, twice a day, and Methotrexate 7.5mg / time, once per week. Results In the treatment group, symptoms, signs and biochemical indicators were significantly improved, and the swelling of the soft tissue around the joints in stage Ⅰ and Ⅱ were also reduced. Besides, osteoporosis was controlled and the progress of destruction to the cartilage of stage Ⅲ was detained, though there was no statistical difference between the two groups after the treatment. Conclusion ShuTongluo liquid is a safe and effective medicine with less adverse reactions in treating rheumatoid arthritis.